| Dr Lisa L Privett, OD | |
|
135 S Bells St, Alamo, TN 38001-1779 | |
| (731) 696-4004 | |
| (731) 696-4009 |
| Full Name | Dr Lisa L Privett |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 31 Years |
| Location | 135 S Bells St, Alamo, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992754295 | NPI | - | NPPES |
| 3598962 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | T1481 (Tennessee) | Primary |
| Provider Name | Lisa K Privett Family Eye Care |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1073791406 PECOS PAC ID: 3577683812 Enrollment ID: O20231219000933 |
News Archive
For the first time, researchers have identified a peptide that can spur cargo transport in nerve cells, a discovery that could help scientists better understand nerve cell function and test possible therapies for neurodegenerative diseases.
Americans are likely to be exposed to unacceptable side effects of FDA-approved drugs such as Vioxx in the future because of fatal flaws in the way new drugs are tested and marketed, according to research to be presented at the annual meeting of the American Sociological Association (ASA).
Athletes with a vocal cord disorder that restricts breathing are more likely to be misdiagnosed and inappropriately treated for exercise-induced asthma, according to research presented today at the Triological Society's 116th Annual Meeting.
ZIOPHARM Oncology, Inc. today announced that the first patient has been dosed in a Phase 1 clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate, in patients with advanced melanoma.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lisa L Privett, OD 135 S Bells St, Alamo, TN 38001-1779 Ph: (731) 696-4004 | Dr Lisa L Privett, OD 135 S Bells St, Alamo, TN 38001-1779 Ph: (731) 696-4004 |
News Archive
For the first time, researchers have identified a peptide that can spur cargo transport in nerve cells, a discovery that could help scientists better understand nerve cell function and test possible therapies for neurodegenerative diseases.
Americans are likely to be exposed to unacceptable side effects of FDA-approved drugs such as Vioxx in the future because of fatal flaws in the way new drugs are tested and marketed, according to research to be presented at the annual meeting of the American Sociological Association (ASA).
Athletes with a vocal cord disorder that restricts breathing are more likely to be misdiagnosed and inappropriately treated for exercise-induced asthma, according to research presented today at the Triological Society's 116th Annual Meeting.
ZIOPHARM Oncology, Inc. today announced that the first patient has been dosed in a Phase 1 clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate, in patients with advanced melanoma.
› Verified 8 days ago
Family Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 135 S Bells St, Alamo, TN 38001 Phone: 731-696-4004 Fax: 731-696-4009 | |
Mrs. Sarah Jordan Collins Shell, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 135 South Bells Street, Alamo, TN 38001 Phone: 731-696-4004 Fax: 731-696-4009 |